KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Leases (2019 - 2022)

Palvella Therapeutics (PVLA) has disclosed Leases for 5 consecutive years, with $3.8 million as the latest value for Q2 2023.

  • On a quarterly basis, Leases rose 5.5% to $3.8 million in Q2 2023 year-over-year; TTM through Jun 2023 was $3.8 million, a 5.5% increase, with the full-year FY2022 number at $3.7 million, down 5.22% from a year prior.
  • Leases was $3.8 million for Q2 2023 at Palvella Therapeutics, up from $3.8 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $4.0 million in Q3 2021 to a low of $3.2 million in Q1 2020.
  • A 5-year average of $3.7 million and a median of $3.8 million in 2021 define the central range for Leases.
  • Peak YoY movement for Leases: grew 19.53% in 2021, then decreased 14.47% in 2022.
  • Palvella Therapeutics' Leases stood at $3.4 million in 2019, then increased by 14.49% to $3.9 million in 2020, then dropped by 0.64% to $3.9 million in 2021, then dropped by 5.22% to $3.7 million in 2022, then increased by 3.0% to $3.8 million in 2023.
  • Per Business Quant, the three most recent readings for PVLA's Leases are $3.8 million (Q2 2023), $3.8 million (Q1 2023), and $3.7 million (Q4 2022).